Santhera Pharmaceuticals Holding AG (SWX:SANN)

SWX:SANN Balance Sheet

Financials in millions CHF. Fiscal year is January - December.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	41.77	22.44	40.93	30.37	1.35	21.21
Cash & Short-Term Investments	41.77	22.44	40.93	30.37	1.35	21.21
Cash Growth	127.04%	-45.17%	34.76%	2144.64%	-93.62%	70.88%
Accounts Receivable	11.48	8.7	9.06	0.44	0.44	0.96
Other Receivables	-	17.33	4.83	1.72	0.65	0.97
Receivables	11.48	26.04	13.89	2.16	1.09	1.94
Inventory	24.64	24.87	17.53	1.81	0.11	0.43
Prepaid Expenses	1.23	0.58	0.37	0.32	0.51	1.07
Other Current Assets	4.45	6.32	3.1	-	-	-
Total Current Assets	83.56	80.24	75.81	34.66	3.07	24.64
Property, Plant & Equipment	1.7	2.01	2.57	0.58	1.01	1.32
Long-Term Investments	0.32	0.32	0.25	0.42	0.44	0.47
Other Intangible Assets	61.43	63.94	68.95	73.97	59.21	64.6
Long-Term Deferred Tax Assets	-	-	-	-	0	0.09
Other Long-Term Assets	0.23	1.58	4.91	-	-	-
Total Assets	147.23	148.09	152.49	109.63	63.73	91.12

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Accounts Payable	7.03	13.58	5.75	3.56	3.9	2.41
Accrued Expenses	13.13	19.4	19.35	9.57	10.85	9.71
Short-Term Debt	-	-	-	-	22.13	1.49
Current Portion of Long-Term Debt	10.47	14.26	6.4	20.94	-	13.88
Current Portion of Leases	0.56	0.59	0.55	0.57	0.62	0.61
Current Income Taxes Payable	1.07	0.89	0.14	0.18	0.55	0.27
Current Unearned Revenue	6.24	0.14	0.06	-	-	-
Other Current Liabilities	9.82	13.31	13.9	10.97	11.36	4.42
Total Current Liabilities	48.32	62.17	46.14	45.79	49.41	32.78
Long-Term Debt	29.16	32.73	31.73	-	21.08	25.8
Long-Term Leases	1.09	1.37	1.94	0.04	0.61	1.2
Long-Term Unearned Revenue	2.9	3.16	1.93	-	-	-
Pension & Post-Retirement Benefits	6.55	6.52	7.67	3.86	1.84	4.79
Other Long-Term Liabilities	65.38	53.96	35.38	-	34.47	25.21
Total Liabilities	153.41	159.9	124.79	49.69	107.41	89.79

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Common Stock	1.56	1.4	1.34	1.26	0.75	54.61
Retained Earnings	-685.46	-663.93	-614.69	-572.72	-627.5	-556.43
Treasury Stock	-0.06	-0.06	-0.07	-0.13	-0.09	-5.02
Comprehensive Income & Other	677.78	650.77	641.11	631.53	583.16	508.17
Shareholders' Equity	-6.17	-11.82	27.7	59.94	-43.69	1.33
Total Liabilities & Equity	147.23	148.09	152.49	109.63	63.73	91.12

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun 30, 2026	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Total Debt	41.28	48.95	40.62	21.55	44.44	42.98
Net Cash (Debt)	0.49	-26.51	0.31	8.82	-43.08	-21.77
Net Cash Growth	-	-	-96.54%	-	-	-
Net Cash Per Share	0.04	-2.04	0.03	0.81	-7.07	-6.37
Filing Date Shares Outstanding	14.35	13.39	12.79	11.32	6.59	4.96
Total Common Shares Outstanding	14.35	13.39	12.79	11.32	6.59	4.96
Working Capital	35.24	18.07	29.67	-11.14	-46.35	-8.14
Book Value Per Share	-0.43	-0.88	2.17	5.30	-6.63	0.27
Tangible Book Value	-67.6	-75.75	-41.25	-14.02	-102.89	-63.27
Tangible Book Value Per Share	-4.71	-5.66	-3.22	-1.24	-15.62	-12.76
Machinery	-	1.51	1.46	1.35	1.46	1.82
Leasehold Improvements	-	1.48	1.48	1.48	1.5	1.54

Data Source: S&P Global Market Intelligence Last updated: Apr 28, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 2, 2026

Data Sources Report a data error